Drugs / Typherix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02121145 | Oct 2013 → Dec 2019 | — | Helsinki University Central Hospital | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01123941 Comparator | May → Jun 2010 | typhoid fever | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Typherix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02121145 ↗ |
| Modality | Vaccine | “In a recent controlled study, the investigators explored cross-reactive immune responses against different Salmonella spp. in healthy volunteers immunized with either the oral...” NCT02121145 ↗ |